Human Papillomavirus-Related Carcinoma — Trials

Human Papillomavirus-Related Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

154 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 67
Recruiting: 36
Ph III recruiting: 2
Growth YoY: —
Industry share: 22%
Top sponsor: National Cancer Institute (NCI)
Termination share: 27.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (13)

clinicaltrialsPublishedShowing 1–14 of 14 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06454175	A Phase I Clinical Trial to Evaluate the Safety of 15-valent HPV Vaccine in Healthy Chinese People Aged 18-45 Years	unknown	Phase 1	72	Shanghai Bovax Biotechnology Co., Ltd.INDUSTRY	1	Jan 6, 2025	clinicaltrials
NCT06339684	HPV Immunological Markers of Cervical Persistent Infection and Oncogenesis(HPVImmuno)	unknown	—	120	Fondazione IRCCS Policlinico San Matteo di PaviaOTHER	1